Head and Neck Cancer Drug Development Summit

Topics

• The mechanisms of inherent and acquired resistance
• The role of the tumor in pathogenesis and treatment response
• How we can tailor the treatment journey to leverage the advantages of HPV-specific immunotherapy, immune checkpoint inhibitors, chemoradiotherapy, and improve patient outcomes
• Where promising avenues for targeted drug approaches for both HPV-positive and -negative subtypes are